Cargando…

Therapeutic effects of STAT3 inhibition by nifuroxazide on murine acute graft graft-vs.-host disease: Old drug, new use

Graft-vs.-host disease (GvHD) is a major and lethal complication of allogeneic bone marrow transplantation (allo-BMT). Although great development has been made, the treatment progress of this disorder is slow. Research has illustrated that STAT3 was critical for T cell alloactivation in GvHD. In the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Huijie, Cui, Jing, Jia, Xiaolong, Zhao, Jingjing, Feng, Yuchen, Zhao, Peijuan, Zang, Dan, Yu, Jian, Zhao, Tiesuo, Wang, Hui, Xu, Kailin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780006/ https://www.ncbi.nlm.nih.gov/pubmed/29152660 http://dx.doi.org/10.3892/mmr.2017.7825

Ejemplares similares

Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation
por: Jia, Huijie, et al.
Publicado: (2016)

Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
por: Ye, Ting-Hong, et al.
Publicado: (2017)

Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
por: Ye, Ting-Hong, et al.
Publicado: (2019)

Therapeutic Injection of a C-Type CpG ODN Induced an Antitumor Immune Response in C57/BL6 Mice of Orthotopically Transplanted Hepatocellular Carcinoma
por: Jia, Huijie, et al.
Publicado: (2016)

Role of STAT3 in regulatory T lymphocyte plasticity during acute graft-vs.-host-disease
por: Fujino, Masayuki, et al.
Publicado: (2013)

GRAFT-VS.-HOST REACTION IN TISSUE CULTURE
por: Auerbach, Robert, et al.
Publicado: (1973)

Macrophage regulation of graft-vs-host disease
por: Hong, Ya-Qun, et al.
Publicado: (2020)

Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions
por: Krieger, Elizabeth, et al.
Publicado: (2020)

Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
por: Zhu, Yongxia, et al.
Publicado: (2016)

Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model
por: Burlion, Aude, et al.
Publicado: (2017)

IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects
por: Liu, Yuejun, et al.
Publicado: (2014)

Graft-vs.-host-associated immune suppression is activated by recognition of allogeneic murine I-A antigens
Publicado: (1983)

Serum-mediated inhibition of graft-vs.-host reaction
Publicado: (1975)

GRAFT-VS.-HOST REACTIONS IN RECIPROCAL HYBRID MICE : I. DISSOCIATION OF T-CELL ACTIVITIES IN THE MIXED LYMPHOCYTE REACTION AND TWO GRAFT-VS.-HOST ASSAYS
por: Morse, Herbert C., et al.
Publicado: (1974)

Murine Models of Steroid Refractory Graft-versus-Host Disease
por: Toubai, Tomomi, et al.
Publicado: (2018)

Anatomical Study of Temporal Fat Compartments and its Clinical Application for Temporal Fat Grafting
por: Huang, Ru-Lin, et al.
Publicado: (2017)

Author Correction: Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
por: Zhu, Yongxia, et al.
Publicado: (2022)

Virotherapy as Potential Adjunct Therapy for Graft-Vs-Host Disease
por: Villa, Nancy Y., et al.
Publicado: (2018)

Graft-vs-Host Disease Colitis After Lung Transplant
por: Kanthasamy, Kavin, et al.
Publicado: (2019)

Follicular Graft Vs Host Reaction: A Rare Presentation
por: Vashisht, Deepak, et al.
Publicado: (2020)

Biomarkers of graft-vs-host disease: Understanding and applications for the future
por: Nagasawa, Masayuki
Publicado: (2021)

Monocyte subsets in bone marrow grafts may contribute to a low incidence of acute graft‐vs‐host disease for young donors
por: Wen, Qi, et al.
Publicado: (2020)

PD-1-siRNA delivered by attenuated Salmonella enhances the antimelanoma effect of pimozide
por: Zhao, Tiesuo, et al.
Publicado: (2019)

Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model
por: Yang, F, et al.
Publicado: (2015)

TIRC7 inhibits Th1 cells by upregulating the expression of CTLA-4 and STAT3 in mice with acute graft-versus-host disease
por: Zhu, Feng, et al.
Publicado: (2020)

Human multipotent adult progenitor cells effectively reduce graft‐vs‐host disease while preserving graft‐vs‐leukemia activity
por: Metheny, Leland, et al.
Publicado: (2021)

Nifuroxazide boosts the anticancer efficacy of palbociclib-induced senescence by dual inhibition of STAT3 and CDK2 in triple-negative breast cancer
por: Wang, Xianzhe, et al.
Publicado: (2023)

Insights into the role of the JAK/STAT signaling pathway in graft-versus-host disease
por: Abboud, Ramzi, et al.
Publicado: (2020)

RAPID VIRAL INDUCTION OF MURINE LYMPHOMAS IN THE GRAFT-VERSUS-HOST REACTION
por: Cornelius, Eugene A.
Publicado: (1972)

Cytokine Detection and Modulation in Acute Graft vs. Host Disease in Mice
por: Knulst, A. C., et al.
Publicado: (1994)

Association of lpr gene with graft-vs.-host disease-like syndrome
Publicado: (1985)

Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease
por: Thangavelu, Govindarajan, et al.
Publicado: (2019)

Dendritic Cell Regulation of Graft-Vs.-Host Disease: Immunostimulation and Tolerance
por: Yu, Hongshuang, et al.
Publicado: (2019)

Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease
por: Piper, Clint, et al.
Publicado: (2019)

The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease
por: Bastian, David, et al.
Publicado: (2019)

Immunomodulatory Effects of Histone Deacetylation Inhibitors in Graft-vs.-Host Disease After Allogeneic Stem Cell Transplantation
por: Xu, Xiaoxiao, et al.
Publicado: (2021)

IL-17C Mitigates Murine Acute Graft-vs.-Host Disease by Promoting Intestinal Barrier Functions and Treg Differentiation
por: Gong, Huanle, et al.
Publicado: (2018)

Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022)

The enhanced antitumour response of pimozide combined with the IDO inhibitor L-MT in melanoma
por: Jia, Huijie, et al.
Publicado: (2018)

Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease
por: Bailey, Christopher, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v91421763uq856n3siiupcn104